Topography of putaminal degeneration in multiple system atrophy: A diffusion magnetic resonance study

There is neuropathologic evidence that, in early stages of the Parkinson variant of multiple system atrophy (MSA‐P), the putamen shows a distinct topographical pathology affecting predominantly the dorsolateral and caudal regions while leaving the rostral to midparts almost intact. We investigated the topographic profile of putaminal degeneration in MSA‐P patients in vivo by means of diffusion‐weighted imaging (DWI), which has been shown to reveal abnormalities in the basal ganglia of patients with MSA‐P compared to patients with PD and healthy controls. For this purpose, regional trace of the diffusion tensor (rTrace(D)) values were determined in the entire, anterior, and posterior putamen in 15 patients with probable MSA‐P, in 20 patients with PD, and in 11 healthy volunteers matched for age and disease duration. MSA‐P patients had significantly higher rTrace(D) values in entire, anterior, and posterior putamen compared to both controls and PD patients. Trace(D) values were significantly higher in the posterior compared to the anterior putamen in the MSA‐P group. There were no significant differences between posterior and anterior putamen in both the control and PD group. Our study demonstrates prominent involvement of the posterior putamen in early disease stages of MSA‐P in vivo by assessing putaminal diffusivity with the help of DWI. © 2006 Movement Disorder Society

[1]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[2]  Klaus Seppi,et al.  Progression of parkinsonism in multiple system atrophy , 2005, Journal of Neurology.

[3]  Werner Jaschke,et al.  Comparison of diffusion‐weighted imaging and [123I]IBZM‐SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[4]  Christian Kremser,et al.  Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.

[5]  C. Büchel,et al.  Voxel‐based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[6]  Juha O Rinne,et al.  Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET , 2003, Synapse.

[7]  Denis Le Bihan,et al.  Looking into the functional architecture of the brain with diffusion MRI , 2003, Nature Reviews Neuroscience.

[8]  M. Savoiardo Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging , 2003, Neurological Sciences.

[9]  C Kremser,et al.  Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.

[10]  Paola Piccini,et al.  Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET study , 2002, Annals of neurology.

[11]  C. Mathias,et al.  Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? , 2002, Neurology.

[12]  E. Louis Vaccines to treat encephalitis lethargica: human experiments at the Neurological Institute of New York, 1929-1940. , 2002, Archives of neurology.

[13]  B. Drayer,et al.  Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. , 2002, Archives of neurology.

[14]  Masanori Ichise,et al.  Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP , 2002, Movement disorders : official journal of the Movement Disorder Society.

[15]  K. Seppi,et al.  A novel grading scale for striatonigral degeneration (multiple system atrophy) , 2002, Journal of Neural Transmission.

[16]  C Kremser,et al.  Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.

[17]  Merja Haaparanta,et al.  Rate of progression in Parkinson's disease: A 6‐[18F]fluoro‐L‐dopa PET study , 2001, Movement disorders : official journal of the Movement Disorder Society.

[18]  H U Rehman,et al.  Multiple system atrophy , 2001, Postgraduate medical journal.

[19]  F. Tison,et al.  Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.

[20]  M. Skalej,et al.  Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.

[21]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[22]  A J Lees,et al.  Clinical usefulness of magnetic resonance imaging in multiple system atrophy , 1998, Journal of neurology, neurosurgery, and psychiatry.

[23]  S. Gilman,et al.  Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. , 1998, Clinical autonomic research : official journal of the Clinical Autonomic Research Society.

[24]  R P Maguire,et al.  Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. , 1997, Brain : a journal of neurology.

[25]  Francesco Federico,et al.  Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders , 1997 .

[26]  I Litvan,et al.  What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. , 1997, Archives of neurology.

[27]  C. Marsden,et al.  Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.

[28]  Y. Hashizume,et al.  Neuronal cell loss of the striatonigral system in multiple system atrophy , 1993, Journal of the Neurological Sciences.

[29]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[30]  Richard S. J. Frackowiak,et al.  Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.

[31]  A. Lees,et al.  Striatonigral degeneration. A clinicopathological study. , 1990, Brain : a journal of neurology.

[32]  R I Grossman,et al.  Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes , 1989, Neurology.